Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371101 | Bioorganic & Medicinal Chemistry Letters | 2011 | 4 Pages |
Abstract
S6K1 (p70 S6 kinase-1) is thought to play a critical role in the development of obesity and insulin resistance, thus making it an attractive target in developing medicines for the treatment of these disorders. We describe a novel thiophene urea class of S6K inhibitors. The lead matter for the development of these inhibitors came from mining the literature for reports of weak off-target S6K activity. These optimized inhibitors exhibit good potency and excellent selectivity for S6K over a panel of 43 kinases.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Ping Ye, Cyrille Kuhn, Miret Juan, Rahul Sharma, Brendan Connolly, Gordon Alton, Hu Liu, Robert Stanton, Natasha M. Kablaoui,